The mTOR-targeting drug temsirolimus enhances the...

Oral Oncology 2011 Vol. 47; Iss. 5

The mTOR-targeting drug temsirolimus enhances the growth-inhibiting effects of the cetuximab–bevacizumab–irradiation combination on head and neck cancer xenografts

Alexandre Bozec, Marie-Christine Etienne-Grimaldi, Jean-Louis Fischel, Anne Sudaka, Nicolas Toussan, Patricia Formento, Gérard Milano
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
47
Year:
2011
Language:
english
Pages:
5
DOI:
10.1016/j.oraloncology.2011.02.020
File:
PDF, 297 KB
english, 2011
Conversion to is in progress
Conversion to is failed